The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIMI Regulatory News (IMI)

Share Price Information for IMI (IMI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,874.00
Bid: 1,882.00
Ask: 1,884.00
Change: -6.00 (-0.32%)
Spread: 2.00 (0.106%)
Open: 1,863.00
High: 1,888.00
Low: 1,863.00
Prev. Close: 1,880.00
IMI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Coronavirus update

30 Mar 2020 07:00

RNS Number : 9560H
IMI PLC
30 March 2020
 

30 March 2020

Coronavirus update

Given the current and rapidly changing developments regarding Coronavirus, IMI plc ('IMI'), the specialist engineering group, issues the following update. This announcement contains inside information.

Protecting our people

Even before the outbreak of the Coronavirus pandemic, our primary concern has always been the safety and well-being of our people, our wider communities, our customers and partners.

Over recent weeks, this commitment has assumed even greater relevance. All of our facilities have implemented additional personal protection measures, intensified hygiene, and social distancing protocols that meet or exceed local and international guidelines. Employees who are able have been working from home for some time. Factory operations have been managed safely and intensively to maximise business continuity and to support our customers.

A crisis response team comprising both divisional leadership and members of the Group Executive meets at least three times per week to closely monitor the situation and co-ordinate our response. We also communicate regularly with all our employees, keeping them informed about the evolving situation and offering guidance on how they can best keep themselves and their colleagues safe.

Financial position

We have entered this period of uncertainty in a strong financial position. As at the end of February, the Group had immediately available liquidity of £393m, comprising £19m of available cash, £293m of undrawn committed bank facilities with our six core relationship banks, and an additional £81m of undrawn uncommitted facilities.

The Group's existing long-term debt, totalling £363m, was raised through the US Private Placement market. This debt is at fixed rates and, aside from £11m due in 2022, matures in 2025 and beyond.

The financial covenants attached to our committed facilities are that EBITDA should be no less than 4 times interest and net debt should be no more than 3 times EBITDA. Those covenant ratios, at 31 December 2019, were 24.0 times and 1.2 times, respectively.

Recent trading

The disruption from Coronavirus to our businesses in the first two months of the year has been relatively modest - with sales and orders being slightly ahead of our earlier guidance. Margins and cash flow remained strong.

The majority of our sites remain at or near normal capacity. Some facilities, which support IMI Precision Engineering's Life Science sector, have received special dispensation to accelerate activity, in order to ramp-up production of key valve components for the world's ventilator manufacturers.

Our operations in China were disrupted for two weeks in early February, but have since returned to normal operations.  However, in some locations, including in Italy and India, sites have had to close temporarily in line with the direction of the authorities. It is expected that site and supply chain disruptions will likely increase in the short-term before global industrial activity returns to normal.

Protecting our future

Whilst we look forward to, and remain confident of, a return to normal trading, we are actively preparing for the short-term disruptions and expected macroeconomic declines brought about by this pandemic. Mitigating actions have already been taken in anticipation of tougher conditions, including a hiring freeze in all but exceptional circumstances, reduced discretionary spending, and reductions to capital expenditure unless vital for health and safety or operations continuity. The Board and Executive Committee members have agreed to a 20% salary reduction, effective 1 May, for at least the next three months.

 

Further cost reduction initiatives are being developed in order to enable the organisation to align its cost base with any reduced market demand. Our leadership is in close communication with key customers around the world to provide them with our support and expertise, and to minimise misalignment as we progress the year.

 

Dividend

Although we remain confident in the strength of our financial position, given the unprecedented business uncertainty brought about by the pandemic, the Board has decided to withdraw its recommendation to pay a final dividend at the AGM in May, thereby preserving £71m of funds to support the long-term position of the Group. This is recognised as a significant decision and one that will be reviewed later in the year, once the trading environment and outlook become clearer.

 

Outlook and guidance

When we presented our 2019 preliminary results on 28 February, we offered guidance for the first half of 2020, subject to the evolving Coronavirus situation. Although the impact on our trading to date has been relatively modest, given the significant volatility within our market environment, we believe it is now prudent to withdraw that guidance. We will continue to offer updates as it becomes appropriate and helpful to do so. Our next formal communication will be the Interim Management Statement planned for release on 7 May 2020.

 

Roy Twite, Chief Executive said "I am incredibly proud and humbled by the commitment, courage and professionalism shown by all our employees as we face this unprecedented disruption to our communities and businesses. It is my firm belief that, by continuing to act decisively, IMI will deliver on its ambitious strategy once this global, human tragedy has been resolved."

 

Enquiries to:

John Dean

IMI

Tel: +44 (0)121 717 3712

Gayden Metcalfe

Teneo

Tel: +44 (0)20 7420 3189

 

The Annual Report is available on the IMI plc website and will be issued along with the Notice of Meeting to shareholders on 2 April 2020.

 

Notes to editors

IMI plc, the specialist engineering company, designs, manufactures and services highly engineered products that control the precise movement of fluids. Its innovative technologies, built around valves and actuators, enable vital processes to operate safely, cleanly, efficiently and cost effectively. The Group works with industrial customers across a range of high growth sectors, including energy, transportation and infrastructure, all of which are benefiting from the impact of long-term global trends including climate change, urbanisation, resource scarcity and an ageing population. IMI employs around 11,000 people, has manufacturing facilities in more than 20 countries and operates a global service network. The Company is listed on the London Stock Exchange. Further information is available at www.imiplc.com.

 

IMI plc is registered in England No. 714275. Its legal entity identifier ('LEI') number is 2138002W9Q21PF751R30.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDDKLFLBXLXBBX
Date   Source Headline
3rd Sep 20184:05 pmRNSTotal Voting Rights
16th Aug 20182:09 pmRNSDirector/PDMR Shareholding
15th Aug 201812:04 pmRNSDirector/PDMR Shareholding
1st Aug 20182:16 pmRNSTotal Voting Rights
31st Jul 20187:00 amRNSInterim results, six months ended 30 June 2018
11th Jul 201811:57 amRNSDirector/PDMR Shareholding
5th Jul 201812:16 pmRNSBlock listing Interim Review
2nd Jul 201812:45 pmRNSTotal Voting Rights
13th Jun 20183:27 pmRNSDirector/PDMR Shareholding
5th Jun 20182:22 pmRNSHolding(s) in Company
1st Jun 201810:29 amRNSTotal Voting Rights
22nd May 201811:44 amRNSDirector/PDMR Shareholding
21st May 20183:55 pmRNSDirector/PDMR Shareholding
18th May 20187:00 amRNSNew non-executive director appointed
11th May 20184:01 pmRNSDirector/PDMR Shareholding
9th May 20182:36 pmRNSDirector/PDMR Shareholding
8th May 20182:09 pmRNSDirector/PDMR Shareholding
3rd May 20182:00 pmRNSResult of AGM
3rd May 20187:00 amRNSInterim Management Statement
1st May 20189:49 amRNSTotal Voting Rights
24th Apr 20184:08 pmRNSHolding(s) in Company
16th Apr 20182:47 pmRNSDirector/PDMR Shareholding
11th Apr 20182:44 pmRNSDirector/PDMR Shareholding
3rd Apr 201812:40 pmRNSTotal Voting Rights
23rd Mar 20183:09 pmRNSAnnual Financial Report
14th Mar 20182:58 pmRNSDirector/PDMR Shareholding
12th Mar 20184:42 pmRNSDirector/PDMR Shareholding
5th Mar 20189:16 amRNSDirector Declaration
2nd Mar 20187:00 amRNSPreliminary results, year ended 31 December 2017
1st Mar 201810:05 amRNSTotal Voting Rights
14th Feb 201811:47 amRNSDirector/PDMR Shareholding
1st Feb 201811:23 amRNSTotal Voting Rights
1st Feb 20187:00 amRNSCompletion of Bimba acquisition
22nd Jan 20187:00 amRNSExecutive Committee change
11th Jan 201812:09 pmRNSSecond Price Monitoring Extn
11th Jan 201812:04 pmRNSPrice Monitoring Extension
10th Jan 201812:14 pmRNSDirector/PDMR Shareholding
4th Jan 20183:09 pmRNSBlock listing Interim Review
2nd Jan 201812:03 pmRNSTotal Voting Rights
20th Dec 20174:07 pmRNSDirector/PDMR Shareholding
14th Dec 20177:00 amRNSAcquisition
13th Dec 20172:18 pmRNSDirector/PDMR Shareholding
13th Dec 201712:12 pmRNSNon-executive director changes
11th Dec 20179:57 amRNSNon-executive director changes
1st Dec 201710:59 amRNSTotal Voting Rights
22nd Nov 201710:26 amRNSHolding(s) in Company
15th Nov 20172:56 pmRNSDirector/PDMR Shareholding
9th Nov 20177:00 amRNSIMI plc Interim Management Statement
1st Nov 20179:33 amRNSTotal Voting Rights
1st Nov 20178:53 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.